ELDN
NASDAQ · Biotechnology
Eledon Pharmaceuticals Inc
$2.37
-0.31 (-11.42%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+411.2% upside
Low Target
$9.42
Average Target
$12.09
High Target
$15.53
Current Price
$2.37
Current
$2.37
$2.37
Target
$12.09
$12.09
$9.42
$12.09 avg
$15.53
Scenario Analysis
Bear Case
$9.42
298.3%
Low target
Base Case
$12.09
+411.2%
Avg target
Bull Case
$15.53
+556.7%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.49
-47.3% from high
52-Week Low
$1.35
+75.2% from low
Target vs 52W High
$12.09
+169.3% vs high
Next Earnings Report
Nov 18, 2026
4d
until earnings
EPS Est: $-0.19
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |